The Micro fluidics chip
Malignant tumors continually shed cancer cells into the blood stream, which then spread to other cells and tissues and lead to metastasis.
Researchers at Massachusetts General Hospital (MGH), Boston, have designed an inexpensive business card size, microfluidics chip for early detection of very low levels of these cells. When blood flows through the device, cancer cells in the blood stick to microscopic posts (80,000 of them) lining the chip. Initial tests have shown that the device is very sensitive.
This technique can detect cells which originate from solid tumors like, breast, lung or prostate cancer. It may be used in future to monitor the changes in the size of the tumor and tailor the treatment to the individual's need. "I think this device is going to turn the field of metastasis upside down," says Mehmet Toner, a bioengineer at MGH and Harvard Medical School, who led the work.
These blood tests may also be used in the future to complement the traditionally used CT scans and biopsies. These tests are inexpensive and non invasive. The researchers are also hoping to use the chip to study genetic changes in the tumour so as to fine tune changes in treatments.
The chip is currently being tested in larger clinical trials of lung and prostate cancers to study how best it can be used.
© 2007 - 2024 NutritionVista.com. All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. All articles and content written by the Nutritionvista.com team for NutritionVista.com are the sole property of J.L.S Healthcare Pvt. Ltd. Content may not be copied without express permission to do so. If you want to link back to an article, please ensure a working link to the article title is used and is functioning at all times.